Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Modern Hasen Pharma Building $43.6 Million Essential Drug Facility

publication date: Oct 25, 2011
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Shanghai Modern Hasen (Shangqiu) Pharmaceutical, a subsidiary of Shanghai Modern Pharmaceutical , announced plans to invest 277 million RMB ($43.6 million) to build a production facility in Shangqiu, Henan province. The new plant will produce drugs that are listed on the essential drug list. More details....

Stock Symbol: (SHA: 600420)     Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...



Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China

>>More events...
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Partners